You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

untreated;

Showing 1 - 25 of 7,098
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemodynamics in People With Untreated Preeclampsia Using

Not yet recruiting
  • Preeclampsia
  • Transthoracic Echocardiography
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 23, 2023

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Recruiting
  • Hepatitis C Virus Infection
  • Contact the patient
  • Brussel, Belgium
    UZ Brussel
Aug 1, 2023

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023

Irritable Bowel Syndrome Trial (Low FODMAP dietary regimen)

Not yet recruiting
  • Irritable Bowel Syndrome
  • Low FODMAP dietary regimen
  • (no location specified)
Jul 23, 2023

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

Not yet recruiting
  • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
  • Ivosidenib 500mg
  • Placebo
  • (no location specified)
Nov 7, 2023

Depression Trial (intermittend theta burst stimulation (iTBS))

Not yet recruiting
  • Depression
  • intermittend theta burst stimulation (iTBS)
  • (no location specified)
Feb 20, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Linperlisib in combination with CHOP
  • (no location specified)
Jul 10, 2023

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Epigenetic Repression
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 14, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Anti-Aging, Skin Aging Trial in Schenefeld (Day Cream cosmetic product compared to untreated side, Night cream cosmetic product

Recruiting
  • Anti-Aging
  • Skin Aging
  • Day Cream cosmetic product compared to untreated side
  • +3 more
  • Schenefeld, Germany
    proderm GmbH
Jul 22, 2022

DLBCL Trial (Acalabrutinib, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Jul 11, 2023

Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

Not yet recruiting
  • Colonic Neoplasms
  • Dostarlimab
  • +2 more
  • (no location specified)
May 3, 2023

Orelabrutinib in Combination With Standard Treatment Regimen for

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Aug 23, 2023

Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Oct 31, 2022

High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
Nov 17, 2022

Metreleptin-Treated vs Untreated Lipodystrophy

Recruiting
  • Lipodystrophy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

    Not yet recruiting
    • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
      • (no location specified)
      Dec 16, 2022

      MDS Over Time - Comparison of Treated vs Untreated Patients

      Completed
      • Myelodysplastic Syndromes
        • Vienna, Austria
          Hanusch Krankenhaus, 3.Medizinische Abteilung
        Nov 21, 2022